Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-24-009047

Chief Business Officer sold 40,000 shares at $14.09 ($563,600)

  • Chief Business Officer acquired 40,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Savill Corrine · Chief Business Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-29 Exercise or conversion : show line 1 in the form 10b5-1 +40,000 $4.30 $172,000 205,990 D
2024-01-29 Sale : show line 2 in the form 10b5-1 −40,000 $14.09 $563,600 165,990 D
Open-market sales · 40,000 sh · avg $14.09 · $563,600

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-01-29 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −13,997 0 D
2024-01-29 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) −26,003 110,331 D
Loading xslF345X05/ownership.xml…